Q32 Bio Inc. Share Price
QTTBQ32 Bio Inc. Stock Performance
Open $5.78 | Prev. Close $5.70 | Circuit Range N/A |
Day Range $5.42 - $5.78 | Year Range $1.34 - $8.01 | Volume 2,732 |
Average Traded $5.53 |
Q32 Bio Inc. Share Price Chart
About Q32 Bio Inc.
Q32 Bio Inc., a clinical-stage biotechnology company, develops novel biologics to restore healthy immune balance in patients with autoimmune and inflammatory diseases driven by pathological immune dysfunction. The company is developing Bempikibart (ADX-914), a fully human antiinterleukin-7 receptor alpha antagonist monoclonal antibody designed to re-regulate adaptive immune function by blocking signaling mediated by interleukin-7 and thymic stromal lymphopoietin for the treatment of atopic dermatitis and alopecia areata. It also develops ADX-096, a C3d mAb CR1 fusion protein for use in ophthalmologic indications, as well as other C3d mAb fusions and nanobodies designed for tissue-targeted complement inhibition. The company was founded in 2017 and is based in Waltham, Massachusetts.
Q32 Bio Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
19-May-26 | $5.72 | $6.00 | +4.35% |
18-May-26 | $6.44 | $5.75 | -8.51% |
15-May-26 | $6.22 | $6.29 | +0.08% |
14-May-26 | $5.83 | $6.28 | +6.44% |
13-May-26 | $5.85 | $5.90 | +1.20% |
12-May-26 | $5.25 | $5.83 | +12.55% |
11-May-26 | $5.40 | $5.18 | -3.00% |